These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 22089622)

  • 1. Haemoglobinopathies in Greece: prevention programme over the past 35 years.
    Loukopoulos D
    Indian J Med Res; 2011 Oct; 134(4):572-6. PubMed ID: 22089622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of the National Thalassaemia and Sickle Cell Disease Prevention Programme in Northern Greece: 15-Year Experience, Practice and Policy Gaps for Natives and Migrants.
    Theodoridou S; Prapas N; Balassopoulou A; Boutou E; Vyzantiadis TA; Adamidou D; Delaki EE; Yfanti E; Economou M; Teli Α; Karakasidou O; Skatharoudi E; Theodoridis T; Voskaridou E
    Hemoglobin; 2018 Jul; 42(4):257-263. PubMed ID: 30501529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of thalassaemia and haemoglobin S syndromes in Greece.
    Fessas P
    Acta Haematol; 1987; 78(2-3):168-72. PubMed ID: 3120466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic Blood Disorders Survey in the Sultanate of Oman.
    Al-Riyami A; Ebrahim GJ
    J Trop Pediatr; 2003 Jul; 49 Suppl 1():i1-20. PubMed ID: 12934793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A national registry of haemoglobinopathies in Greece: deducted demographics, trends in mortality and affected births.
    Voskaridou E; Ladis V; Kattamis A; Hassapopoulou E; Economou M; Kourakli A; Maragkos K; Kontogianni K; Lafioniatis S; Vrettou E; Koutsouka F; Papadakis A; Mihos A; Eftihiadis E; Farmaki K; Papageorgiou O; Tapaki G; Maili P; Theohari M; Drosou M; Kartasis Z; Aggelaki M; Basileiadi A; Adamopoulos I; Lafiatis I; Galanopoulos A; Xanthopoulidis G; Dimitriadou E; Mprimi A; Stamatopoulou M; Haile ED; Tsironi M; Anastasiadis A; Kalmanti M; Papadopoulou M; Panori E; Dimoxenou P; Tsirka A; Georgakopoulos D; Drandrakis P; Dionisopoulou D; Ntalamaga A; Davros I; Karagiorga M;
    Ann Hematol; 2012 Sep; 91(9):1451-8. PubMed ID: 22526366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carrier screening and prenatal diagnosis of hemoglobinopathies. A study of indigenous and immigrant couples in northern Greece, over the last 5 years.
    Theodoridou S; Alemayehou M; Prappas N; Karakasidou O; Aletra V; Plata E; Tsaftaridis P; Karababa P; Boussiou M; Sinopoulou K; Hatzi A; Voskaridou E; Loutradi A; Manitsa A
    Hemoglobin; 2008; 32(5):434-9. PubMed ID: 18932067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prenatal diagnosis of thalassemia and of the sickle cell syndromes in Greece.
    Loukopoulos D; Hadji A; Papadakis M; Karababa P; Sinopoulou K; Boussiou M; Kollia P; Xenakis M; Antsaklis A; Mesoghitis S
    Ann N Y Acad Sci; 1990; 612():226-36. PubMed ID: 2291550
    [No Abstract]   [Full Text] [Related]  

  • 8. Screening for sickle cell disease and thalassaemia: a systematic review with supplementary research.
    Davies SC; Cronin E; Gill M; Greengross P; Hickman M; Normand C
    Health Technol Assess; 2000; 4(3):i-v, 1-99. PubMed ID: 10840658
    [No Abstract]   [Full Text] [Related]  

  • 9. Antenatal screening for haemoglobinopathies: current status, barriers and ethics.
    Chakravorty S; Dick MC
    Br J Haematol; 2019 Nov; 187(4):431-440. PubMed ID: 31509241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Invasive & non-invasive approaches for prenatal diagnosis of haemoglobinopathies: experiences from India.
    Colah RB; Gorakshakar AC; Nadkarni AH
    Indian J Med Res; 2011 Oct; 134(4):552-60. PubMed ID: 22089620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sickle cell disease and thalassaemia antenatal screening programme in England over 10 years: a review from 2007/2008 to 2016/2017.
    Weil LG; Charlton MR; Coppinger C; Daniel Y; Streetly A
    J Clin Pathol; 2020 Apr; 73(4):183-190. PubMed ID: 31771971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of thalassemia.
    Loukopoulos D; Kaltsoya-Tassiopoulou A; Fessas P
    Schweiz Med Wochenschr; 1983 Oct; 113(40):1419-27. PubMed ID: 6316486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of earlier antenatal screening for sickle cell disease and thalassaemia in primary care: cluster randomised trial.
    Dormandy E; Gulliford M; Bryan S; Roberts TE; Calnan M; Atkin K; Karnon J; Logan J; Kavalier F; Harris HJ; Johnston TA; Anionwu EN; Tsianakas V; Jones P; Marteau TM
    BMJ; 2010 Oct; 341():c5132. PubMed ID: 20923841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Monitoring pregnant patients from risk countries with sickle cell disease and thalassemia. Clinical aspects, screening and prenatal diagnosis].
    Dickerhoff R; Kulozik AE; Kohne E
    Geburtshilfe Frauenheilkd; 1993 Apr; 53(4):215-21. PubMed ID: 8491363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mass spectrometric analysis of unknown haemoglobin fractions identified by high-performance liquid chromatography in an antenatal screening programme.
    Griffin M; Eyre J; Dack S; Wright J
    J Clin Pathol; 2015 May; 68(5):388-90. PubMed ID: 25694443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Counselling for prenatal diagnosis of sickle cell disease and beta thalassaemia major: a four year experience.
    Anionwu EN; Patel N; Kanji G; Renges H; Brozović M
    J Med Genet; 1988 Nov; 25(11):769-72. PubMed ID: 3236357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prenatal diagnosis of hemoglobinopathies in Ontario, Canada.
    Basran RK; Patterson M; Walker L; Nakamura LM; Eng B; Chui DH; Waye JS
    Ann N Y Acad Sci; 2005; 1054():507-10. PubMed ID: 16339708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Community control of hereditary anaemias: memorandum from a WHO meeting.
    Bull World Health Organ; 1983; 61(1):63-80. PubMed ID: 6601544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thirty-year experience in preventing haemoglobinopathies in Greece: achievements and potentials for optimisation.
    Ladis V; Karagiorga-Lagana M; Tsatra I; Chouliaras G
    Eur J Haematol; 2013 Apr; 90(4):313-22. PubMed ID: 23331260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significant haemoglobinopathies: A guideline for screening and diagnosis: A British Society for Haematology Guideline: A British Society for Haematology Guideline.
    Bain BJ; Daniel Y; Henthorn J; de la Salle B; Hogan A; Roy NBA; Mooney C; Langabeer L; Rees DC;
    Br J Haematol; 2023 Jun; 201(6):1047-1065. PubMed ID: 37271570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.